TY  - GEN
AU  - Van Cutsem,E
AU  - Prenen,H
AU  - D'Haens,G
AU  - Bennouna,J
AU  - Carrato,A
AU  - Ducreux,M
AU  - Bouché,O
AU  - Sobrero,A
AU  - Latini,L
AU  - Staines,H
AU  - Oum'Hamed,Z
AU  - Dressler,H
AU  - Studeny,M
AU  - Capdevila,J
TI  - A phase I/II, open-label, randomised study of nintedanib plus mFOLFOX6 versus bevacizumab plus mFOLFOX6 in first-line metastatic colorectal cancer patients
SN  - 1569-8041
PY  - 2016///0707
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Bevacizumab
KW  - administration & dosage
KW  - Colorectal Neoplasms
KW  - Female
KW  - Fluorouracil
KW  - Follow-Up Studies
KW  - Humans
KW  - Indoles
KW  - Leucovorin
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Neoplasm Staging
KW  - Organoplatinum Compounds
KW  - Oxaliplatin
KW  - Prognosis
KW  - Survival Rate
N1  - Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/annonc/mdv286
ER  -